StockData
Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc. (VYGR) stock

VYGRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3058% below fair value
$1.67+0.15 (+9.87%)

Close on Nov 18, 2026Market cap $102.90MP/E –Yield –

Voyager Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Voyager Therapeutics's pe ratio was 9.4× on Jan 31, 2025, against 2.9× a year earlier. Over the last 4 years it ranged from 0.3× to 45.5×, with a median of 5.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20259.4×−0.4
2024Dec 31, 20249.8×+2.9
2023Dec 29, 20236.9×−1.0
2021Oct 29, 20217.9×+1.0
2020Dec 31, 20206.9×−6.0
2017Jul 31, 201712.9×+5.3
2016Dec 30, 20167.6×+6.9
2015Dec 31, 20150.7×–

More Voyager Therapeutics figures

See a number that looks wrong?